More than 8,000 researchers and clinicians with expertise in multiple sclerosis will gather Sept. 14 – 17, in London, for the 32nd annual European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
More than 2,000 abstracts will be presented within the 61 sessions planned for the congress. Sessions will focus on five topics: imaging, immunomodulation and immunosuppression, clinical assessment tools, long-term treatment monitoring, and risk management for disease modifying treatments.
Participants will also explore new therapies that modulate immune response because immune system-mediated tissue damage and mitochondrial dysfunction are emerging as two mechanisms that seem to cause MS.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.